3-(8-Hydroxy-3-methyl-1,4-dioxo-1,4-dihydro-naphthalen-2-yl)-propionic acid

ID: ALA152263

Chembl Id: CHEMBL152263

Max Phase: Preclinical

Molecular Formula: C14H12O5

Molecular Weight: 260.24

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=C(CCC(=O)O)C(=O)c2c(O)cccc2C1=O

Standard InChI:  InChI=1S/C14H12O5/c1-7-8(5-6-11(16)17)14(19)12-9(13(7)18)3-2-4-10(12)15/h2-4,15H,5-6H2,1H3,(H,16,17)

Standard InChI Key:  NXZAUINGPRFZPU-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA152263

    ---

Associated Targets(Human)

MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

TPR Trypanothione reductase (965 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma brucei (78846 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DLD Dihydrolipoamide dehydrogenase (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 260.24Molecular Weight (Monoisotopic): 260.0685AlogP: 1.95#Rotatable Bonds: 3
Polar Surface Area: 91.67Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.61CX Basic pKa: CX LogP: 2.20CX LogD: -1.19
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.87Np Likeness Score: 1.49

References

1. Salmon-Chemin L, Buisine E, Yardley V, Kohler S, Debreu MA, Landry V, Sergheraert C, Croft SL, Krauth-Siegel RL, Davioud-Charvet E..  (2001)  2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity.,  44  (4): [PMID:11170645] [10.1021/jm001079l]
2. Bao N, Ou J, Xu M, Guan F, Shi W, Sun J, Chen L..  (2017)  Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.,  137  [PMID:28558333] [10.1016/j.ejmech.2017.05.046]
3. Bao N, Ou J, Li N, Zou P, Sun J, Chen L..  (2018)  Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations.,  154  [PMID:29772386] [10.1016/j.ejmech.2018.04.047]

Source